Patients’ Preferences for Models of Follow-Up Care During or After Initial Cancer Treatment in Greece: Development of the Qualitative Phase, and Protocol for a Discrete Choice Experiment Choice Studies
Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis Choice Studies
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies Methodological
Partitioned survival and state transition models for healthcare decision making in oncology: where are we now? Methodological
Exploring heterogeneity in histology-independent technologies and the implications for cost-effectiveness Methodological
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework Reviews
Modeling benefits, costs, and affordability of a novel gene therapy in hemophilia A Economic Evaluations
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies Methodological
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma Methodological
